Momentum Group Limited (JSE:MTM)

South Africa · Delayed Price · Currency is ZAR · Price in ZAc

4,028.00

+6.00 (0.15%)

Aug 21, 2026, 5:00 PM SAST

11.73% (1Y)

Market Cap	51.46B +10.8%
Revenue (ttm)	63.23B +6.2%
Net Income	6.03B +20.4%
EPS	4.47 +23.6%
Shares Out	1.28B
PE Ratio	9.02
Forward PE	7.41
Dividend	2.20 (5.37%)
Ex-Dividend Date	Apr 8, 2026

Volume	1,311,691
Open	4,030.00
Previous Close	4,022.00
Day's Range	3,993.00 - 4,133.00
52-Week Range	3,201.00 - 4,290.00
Beta	0.23
Analysts	Buy
Price Target	4,519.40 (+12.2%)
Earnings Date	Sep 17, 2026

About Momentum Group

Momentum Group Limited, together with its subsidiaries, provides insurance and financial services in South Africa and internationally. It operates through Momentum Retail, Momentum Investments, Metropolitan Life, Momentum Corporate, Momentum Metropolitan Health, Guardrisk, Momentum Insure, Momentum Metropolitan Africa, India, and Shareholders segments. The company offers long and short-term insurance; employee benefits; asset management, property management, investments, and savings; health administration services, such as managed care and well... [Read more]

Industry Insurance - Diversified

Sector Financials

CEO Jeanette Marais

Employees 13,390

Stock Exchange Johannesburg Stock Exchange

Ticker Symbol MTM

Full Company Profile

Financial Performance

In fiscal year 2025, Momentum Group's revenue was 61.73 billion, an increase of 11.31% compared to the previous year's 55.46 billion. Earnings were 5.98 billion, an increase of 55.39%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for MTM stock is "Buy." The 12-month stock price target is ZAC 4,519, which is an increase of 12.20% from the latest price.

Price Target

ZAC 4,519

(12.20% upside)

Analyst Consensus: Buy

Stock Forecasts

News

Momentum Group Transcript: CMD 2026

The group is on track to achieve its Impact Strategy targets by FY2027, with strong financial performance, robust capital management, and significant progress in digital transformation and cost optimization. Strategic business unit initiatives, international expansion, and a federated operating model are driving sustainable growth and positioning the group for long-term success.

2 months ago - Transcripts

Momentum Group Slides: FY 2026

Momentum Group has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 2, 2026.

2 months ago - Filings

Momentum Group Earnings Call Transcript: Q3 2026

Normalized headline earnings rose 15% year-on-year to ZAR 5.5 billion, with strong segment contributions and ROE at 23.3%. Cost optimization and the Bonitas onboarding were key highlights, while VNB margin remains a challenge amid industry shifts.

2 months ago - Transcripts

Momentum Group Earnings release: Q3 2026

Momentum Group released its Q3 2026 earnings on June 1, 2026, summarizing the period's financial results.

2 months ago - Filings

Momentum Group Earnings Call Transcript: Q2 2026

Normalized headline earnings rose 8% to ZAR 3.7 billion, with strong operational profit growth and sales up 11%. ROE remains high at 24%, while VNB declined 15% year-on-year. The Bonitas contract will significantly expand health administration, and capital is being retained to strengthen solvency.

5 months ago - Transcripts

Momentum Group Quarterly report: Q2 2026

Momentum Group has published its Q2 2026 quarterly earnings report on March 19, 2026.

5 months ago - Filings

Momentum Group Slides: Q2 2026

Momentum Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on March 19, 2026.

5 months ago - Filings

Momentum Group Earnings Call Transcript: Q1 2026

Normalized headline earnings reached ZAR 1.76 billion, with strong operational performance and 8% sales growth, though VNB declined due to lower annuity sales. SCR ratio remains within target, and cost savings continue to support margins. F2027 targets for earnings and ROE remain on track.

9 months ago - Transcripts